Skip to Content

QUINAGOLIDE 75 MICROGRAMS TABLETS

Active substance(s): QUINAGOLIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
PACKAGE LEAFLET: INFORMATION FOR THE USER

NORPROLAC® 75 micrograms TABLETS / QUINAGOLIDE 75 micrograms TABLETS
(quinagolide hydrochloride)
This product is available as any of the above names but will be referred to as Norprolac throughout
the remainder of this leaflet. Please note that the leaflet also contains information about other
strengths (Norprolac 25 micrograms and 50 micrograms Tablets).
Read all of this leaflet carefully before you start taking this medicine.

Keep this leaflet, you may need to use it again

If you have further questions, please ask your doctor or pharmacist

This medicine has been prescribed for you personally and you should not pass it on to others. It
may harm them, even if their symptoms are the same as yours.
In this leaflet:
1. What Norprolac is and what it is used for
2. Before you take Norprolac
3. How to take Norprolac
4. Possible side effects
5. How to store Norprolac
6. Further information
1. WHAT NORPROLAC IS AND WHAT IT IS USED FOR
Norprolac is for oral use only. It is available in strengths of 25 micrograms, 50 micrograms and 75
micrograms. Norprolac contains quinagolide which decreases the production of the hormone prolactin.
Norprolac is used to treat conditions resulting from high levels of prolactin in the blood
(hyperprolactinaemia) including:
• excess production of breast milk
• changes in menstrual bleeding patterns
• infertility
• reduced sexual drive.
2. BEFORE YOU TAKE NORPROLAC
Do not take Norprolac:
• if you have a medical condition affecting your liver or kidneys
• if you are allergic to any of the ingredients listed in Section 6
If you are pregnant or planning a pregnancy, please refer to the pregnancy section of this leaflet.
Before taking Norprolac:
• please consult your doctor if you have ever had any mental illness.
• Norprolac may cause your blood pressure to drop when you stand up, particularly for the first few
days of treatment or following an increase in your dosage. This may result in reduced alertness or
fainting. To avoid this, stand up slowly from a sitting or lying down position. Your doctor will
normally check your blood pressure during the first few days of treatment and when increasing your
dosage.
• Inform your doctor if you or your family/carer notices that you are developing urges or cravings to
behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to
carry out certain activities that could harm yourself or others. These are called impulse control
disorders and can include behaviours such as addictive gambling, excessive eating or spending, an
abnormally high sex drive or an increase in sexual thoughts or feelings. Your doctor may need to
adjust or stop your dose.
Taking/using other medicines:
Please inform your doctor or pharmacist if you are taking or have recently taken or used any other
medicines – even those not prescribed.
Taking Norprolac with drink:
Drinking alcohol may increase the side effects of Norprolac.
If this happens, you should avoid drinking alcohol while you are on treatment with Norprolac.
Pregnancy:
• Fertility may be restored while you are on Norprolac, so women of child-bearing age who do not
wish to become pregnant should use a reliable method of contraception.
• If you are planning a pregnancy, it is recommended that Norprolac is stopped when pregnancy is
confirmed. However, some patients may need to continue treatment with Norprolac during
pregnancy. If you become pregnant while you are on Norprolac, tell your doctor as soon as
possible.
Breast-feeding:
Norprolac reduces production of breast-milk, so it is not normally possible to breast-feed while you are
taking it. You should not breast-feed even if it is possible to do so. This is because it is not known
whether the active ingredient in Norprolac passes into breast-milk.
Driving and using machines:
While you are on Norprolac, caution is advised if you drive or operate machinery. This is because
Norprolac:
• may cause your blood pressure to drop, particularly during the first few days of treatment or
following dosage increase. This may result in reduced alertness or fainting.
• may also cause somnolence (drowsiness or sleepiness).
If you experience any of these effects, please do not drive or engage in any other activity (e.g.
operating machinery) where impaired alertness may put you or others at risk of serious injury or death
and please consult your doctor, as your dose may need to be adjusted.
Important information about some of the ingredients in Norprolac:
Norprolac contains the ingredient, lactose. Therefore, if you have been told by your doctor that you
have an intolerance to some sugars (including lactose), contact your doctor before taking this
medicinal product.
3. HOW TO TAKE NORPROLAC
Adults:
It is important to take your medicine as directed by your doctor. The label on your medicine should tell
you how much to take and when to take it. If it does not, or you are not sure, ask your doctor or
pharmacist.
Elderly:
Take this medicine only if your doctor has decided that this is appropriate for you. Follow the
instructions given to you very carefully.
The tablets should only be removed from the blister when it is time to take your medicine.
• Your treatment will normally begin with the ‘starter pack’ and you will take one 25 micrograms tablet
daily (one light pink tablet) for the first three days (marked Day 1, Day 2 and Day 3 on the blister
strip).
• This is followed by one 50 micrograms tablet daily (one very pale blue tablet) for the next three
days (marked Day 4, Day 5 and Day 6 on the blister strip).
• From Day 7, the recommended dose is one 75 micrograms tablet daily (one whitish tablet). Most
patients require a daily dose of 75 to 150 micrograms. Some patients require a daily dose of 300
micrograms or higher. Your doctor will tell you if you need a higher dose. You should not change
the dose yourself.
Norprolac should be taken once daily at bedtime preferably with a snack. Remove the tablet from the
blister by pushing it through the foil and place it in your mouth. Swallow it with a mouthful of water.

If you take more Norprolac than you should:
If you take more Norprolac than you should, tell your doctor immediately or go to your nearest
casualty department.
If you forget to take Norprolac:
If you forget to take a dose, take it as soon as you remember. However, if you do not remember until it
is nearly time for the next dose, take your next dose as usual and carry on as before. Do not take
double doses to make up for a dose that you miss.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Norprolac can have side effects. These are most common during the first few days
of treatment and tend to go away on continuing treatment.
Very common side effects (affect more than 10 of every 100 patients treated):
• Nausea
• Vomiting
• Headache
• Dizziness
• Tiredness.
Common side effects (affect between 1 and 10 of every 100 patients treated):
• Loss of appetite
• Abdominal pain
• Constipation or diarrhoea
• Insomnia
• Increased water retention
• Flushing
• Nasal congestion and a drop in blood pressure, which may result in fainting.
Rare side effects (affect between 1 and 10 of every 10,000 patients treated):
• Somnolence (drowsiness or sleepiness).
Very rare side effects (affect less than 1 of every 10,000 patients treated):
• Treatment with Norprolac has been associated with a change in mental status, which is reversible
when treatment is stopped.
Other side effects include:
Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or
others, which may include:
• strong impulse to gamble excessively despite serious personal or family consequences
• altered or increased sexual interest and behaviour of significant concern to you or to others, for
example, an increased sexual drive
• uncontrollable excessive shopping or spending
• binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more
food than normal and more than is needed to satisfy your hunger).
Tell your doctor if you experience any of these behaviours; they will discuss ways of managing or
reducing the symptoms.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme
at: www.mhra.gov.uk/yellowcard
By reporting side effects, you can help provide more information on the safety of this medicine.
5. STORING NORPROLAC
• Keep out of the sight and reach of children.
• Do not store above 25°C. Store in the original package in order to protect from light and moisture.
• Do not take the tablets past the expiry date on the packaging.
• If you are unsure about the storage, ask your pharmacist. It is best to return all old and unused
medicines to your pharmacist for safe disposal.
• If the tablets become discoloured or show any other signs of deterioration, you should ask your
doctor or pharmacist who will advise you what to do.
6. FURTHER INFORMATION
What Norprolac contains
Your medicine is called Norprolac 75 micrograms Tablets. They are for oral use only.
Each tablet contains 81.9 micrograms quinagolide hydrochloride equivalent to 75 micrograms of the
active ingredient, quinagolide.
• Norprolac also contains: lactose monohydrate, colloidal anhydrous silica, magnesium stearate,
hypromellose, maize starch and microcrystalline cellulose.
What Norprolac looks like and contents of the pack
Norprolac are white, round tablets marked "NORPROLAC" on one side and "75" on the reverse.
Norprolac tablets are available as a blister pack of 30 tablets.
PL No: 15814/1095

POM

Norprolac is manufactured by Ferring GmbH, Kiel, Germany.
Procured from within the EU and repackaged by the Product Licence holder: O.P.D. Laboratories Ltd.,
Unit 6 Colonial Way, Watford, Herts WD24 4PR.
Leaflet revision and issue date (Ref.): 13.08.2014.
Norprolac is a registered trademark of Ferring B.V., The Netherlands.
To request a copy of this leaflet in Braille, large print or audio please call 01923 332 796.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide